Company Analysis Kissei Pharmaceutical Co. Ltd
1. Summary
Advantages
- Price (27.13 $) is less than fair price (36.95 $)
- Dividends (5.96%) are higher than the sector average (0%).
- The stock's return over the last year (11.04%) is higher than the sector average (-0.1092%).
- Current debt level 0.5135% is below 100% and has decreased over 5 years from 100.92%.
- The company's current efficiency (ROE=10.08%) is higher than the sector average (ROE=0%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Kissei Pharmaceutical Co. Ltd | Index | ||
---|---|---|---|
7 days | -12.1% | 0.2% | -0.3% |
90 days | 0% | -3.6% | 17.4% |
1 year | 11% | -0.1% | 11.1% |
KSPHF vs Sector: Kissei Pharmaceutical Co. Ltd has outperformed the "" sector by 11.15% over the past year.
KSPHF vs Market: Kissei Pharmaceutical Co. Ltd has underperformed the market marginally by -0.0868% over the past year.
Stable price: KSPHF is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: KSPHF with weekly volatility of 0.2123% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (27.13 $) is lower than the fair price (36.95 $).
Price significantly below the fair price: The current price (27.13 $) is 36.2% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (14.05) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (14.05) is higher than that of the market as a whole (0).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.709) is higher than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (0.709) is higher than that of the market as a whole (0).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.07) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (2.07) is higher than that of the market as a whole (0).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.22) is higher than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (7.22) is higher than that of the market as a whole (0).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 8533.62% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (8533.62%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (10.08%) is higher than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (10.08%) is higher than that of the market as a whole (0%).
5.5. ROA
ROA vs Sector: The company's ROA (8.5%) is higher than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (8.5%) is higher than that of the market as a whole (0%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.96% is higher than the average for the sector '0%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.96% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 5.96% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (33.35%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription